PMC:7195088 / 49580-50363
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1480 | 193-201 | Species | denotes | patients | Tax:9606 |
| 1481 | 156-167 | Chemical | denotes | chloroquine | MESH:D002738 |
| 1482 | 171-189 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 1483 | 594-605 | Chemical | denotes | chloroquine | MESH:D002738 |
| 1484 | 606-624 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 1485 | 207-215 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T274 | 207-215 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T289 | 477-480 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T99101 | 156-167 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T35786 | 171-189 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T33236 | 594-605 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T38375 | 606-624 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T381 | 0-259 | Sentence | denotes | Recently, Cortegiani et al. [40] reviewed the available information on ongoing case series, comparative observational studies and RCT evaluating the use of chloroquine or hydroxychloroquine in patients with COVID-19 and registered in Chinese or US registries. |
| T382 | 260-312 | Sentence | denotes | They found 23 studies, all being conducted in China. |
| T383 | 313-502 | Sentence | denotes | However, in the few weeks after the paper was made available online (10 March 2020), the number of registered studies being conducted in countries other than China has multiplied (Table 2). |
| T384 | 503-783 | Sentence | denotes | In particular, results of registered RCT are necessary to guide (or discourage) the use of chloroquine/hydroxychloroquine in two different settings: prophylaxis of exposed individuals and treatment of proven cases, stratified for the severity of clinical presentation/progression. |